{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:30:40Z","timestamp":1792114240853,"version":"4.4.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009526","name":"Amrita Vishwa Vidyapeetham","doi-asserted-by":"publisher","award":["K-PHAR-22-662"],"award-info":[{"award-number":["K-PHAR-22-662"]}],"id":[{"id":"10.13039\/100009526","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.lfs.2024.122818","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T17:58:41Z","timestamp":1718215121000},"page":"122818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Mast cells and the gut-liver Axis: Implications for liver disease progression and therapy"],"prefix":"10.1016","volume":"351","author":[{"given":"Bhagyalakshmi","family":"Nair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adithya Jayaprakash","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Tergaonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lekshmi R.","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2024.122818_bb0005","doi-asserted-by":"crossref","unstructured":"H. Devarbhavi, S. K. Asrani, J. P. Arab, Y. A. Nartey, E. Pose, and P. S. Kamath, \u201cGlobal burden of liver disease: 2023 update,\u201d J. Hepatol., vol. 79, no. 2, pp. 516\u2013537, Aug. 2023, doi:https:\/\/doi.org\/10.1016\/j.jhep.2023.03.017.","DOI":"10.1016\/j.jhep.2023.03.017"},{"key":"10.1016\/j.lfs.2024.122818_bb0010","doi-asserted-by":"crossref","unstructured":"P. C. Konturek et al., \u201cGut\u2212liver Axis: how do gut Bacteria influence the liver?,\u201d Med Sci (Basel), vol. 6, no. 3, p. 79, Sep. 2018, doi:https:\/\/doi.org\/10.3390\/medsci6030079.","DOI":"10.3390\/medsci6030079"},{"key":"10.1016\/j.lfs.2024.122818_bb0015","doi-asserted-by":"crossref","unstructured":"Q. Song and X. Zhang, \u201cThe Role of Gut\u2013Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC,\u201d Biomedicines, vol. 10, no. 3, p. 524, Feb. 2022, doi:https:\/\/doi.org\/10.3390\/biomedicines10030524.","DOI":"10.3390\/biomedicines10030524"},{"key":"10.1016\/j.lfs.2024.122818_bb0020","doi-asserted-by":"crossref","unstructured":"A. Albillos, A. De Gottardi, and M. Rescigno, \u201cThe gut-liver axis in liver disease: pathophysiological basis for therapy,\u201d J. Hepatol., vol. 72, no. 3, pp. 558\u2013577, Mar. 2020, doi:https:\/\/doi.org\/10.1016\/j.jhep.2019.10.003.","DOI":"10.1016\/j.jhep.2019.10.003"},{"key":"10.1016\/j.lfs.2024.122818_bb0025","doi-asserted-by":"crossref","unstructured":"M. Albert-Bayo et al., \u201cIntestinal mucosal mast cells: key modulators of barrier function and homeostasis,\u201d Cells, vol. 8, no. 2, p. 135, Feb. 2019, doi:https:\/\/doi.org\/10.3390\/cells8020135.","DOI":"10.3390\/cells8020135"},{"key":"10.1016\/j.lfs.2024.122818_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.964887","article-title":"Exploring the role of mast cells in the progression of liver disease","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.lfs.2024.122818_bb0035","doi-asserted-by":"crossref","unstructured":"V. Jarido et al., \u201cThe emerging role of mast cells in liver disease,\u201d American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 313, no. 2, pp. G89\u2013G101, Aug. 2017, doi:https:\/\/doi.org\/10.1152\/ajpgi.00333.2016.","DOI":"10.1152\/ajpgi.00333.2016"},{"key":"10.1016\/j.lfs.2024.122818_bb0040","doi-asserted-by":"crossref","unstructured":"G. Cildir, H. Pant, A. F. Lopez, and V. Tergaonkar, \u201cThe transcriptional program, functional heterogeneity, and clinical targeting of mast cells,\u201d J. Exp. Med., vol. 214, no. 9, pp. 2491\u20132506, Sep. 2017, doi:https:\/\/doi.org\/10.1084\/jem.20170910.","DOI":"10.1084\/jem.20170910"},{"key":"10.1016\/j.lfs.2024.122818_bb0045","doi-asserted-by":"crossref","unstructured":"G. Traina, \u201cMast cells in gut and brain and their potential role as an emerging therapeutic target for neural diseases,\u201d Front. Cell. Neurosci., vol. 13, p. 345, Jul. 2019, doi:https:\/\/doi.org\/10.3389\/fncel.2019.00345.","DOI":"10.3389\/fncel.2019.00345"},{"key":"10.1016\/j.lfs.2024.122818_bb0050","doi-asserted-by":"crossref","unstructured":"H. Francis and C. J. Meininger, \u201cA review of mast cells and liver disease: what have we learned?,\u201d Dig. Liver Dis., vol. 42, no. 8, pp. 529\u2013536, Aug. 2010, doi:https:\/\/doi.org\/10.1016\/j.dld.2010.02.016.","DOI":"10.1016\/j.dld.2010.02.016"},{"key":"10.1016\/j.lfs.2024.122818_bb0055","doi-asserted-by":"crossref","unstructured":"L. Hargrove et al., \u201cIsolation and characterization of hepatic mast cells from cholestatic rats,\u201d Lab. Investig., vol. 96, no. 11, pp. 1198\u20131210, Nov. 2016, doi:https:\/\/doi.org\/10.1038\/labinvest.2016.89.","DOI":"10.1038\/labinvest.2016.89"},{"key":"10.1016\/j.lfs.2024.122818_bb0060","doi-asserted-by":"crossref","unstructured":"D. Markose, P. Kirkland, P. Ramachandran, and N. C. Henderson, \u201cImmune cell regulation of liver regeneration and repair,\u201d Journal of Immunology and Regenerative Medicine, vol. 2, pp. 1\u201310, Sep. 2018, doi:https:\/\/doi.org\/10.1016\/j.regen.2018.03.003.","DOI":"10.1016\/j.regen.2018.03.003"},{"key":"10.1016\/j.lfs.2024.122818_bb0065","doi-asserted-by":"crossref","unstructured":"J. S. Dahlin, M. Maurer, D. D. Metcalfe, G. Pejler, R. Sagi-Eisenberg, and G. Nilsson, \u201cThe ingenious mast cell: contemporary insights into mast cell behavior and function,\u201d Allergy, vol. 77, no. 1, pp. 83\u201399, Jan. 2022, doi:https:\/\/doi.org\/10.1111\/all.14881.","DOI":"10.1111\/all.14881"},{"key":"10.1016\/j.lfs.2024.122818_bb0070","doi-asserted-by":"crossref","unstructured":"E. G. Peters, W. J. De Jonge, B. J. J. Smeets, and M. D. P. Luyer, \u201cThe contribution of mast cells to postoperative ileus in experimental and clinical studies,\u201d Neurogastroenterology Motil, vol. 27, no. 6, pp. 743\u2013749, Jun. 2015, doi:https:\/\/doi.org\/10.1111\/nmo.12579.","DOI":"10.1111\/nmo.12579"},{"issue":"23","key":"10.1016\/j.lfs.2024.122818_bb0075","doi-asserted-by":"crossref","first-page":"10743","DOI":"10.7150\/thno.46719","article-title":"Mast cells as a unique hematopoietic lineage and cell system: from Paul Ehrlich\u2019s visions to precision medicine concepts","volume":"10","author":"Valent","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.lfs.2024.122818_bb0080","doi-asserted-by":"crossref","first-page":"1213320","DOI":"10.3389\/fmed.2023.1213320","article-title":"Mast cell-mediated immune regulation in health and disease","volume":"10","author":"Dileepan","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.lfs.2024.122818_bb0085","doi-asserted-by":"crossref","unstructured":"S. Tanaka and K. Furuta, \u201cRoles of IgE and histamine in mast cell maturation,\u201d Cells, vol. 10, no. 8, p. 2170, Aug. 2021, doi:https:\/\/doi.org\/10.3390\/cells10082170.","DOI":"10.3390\/cells10082170"},{"key":"10.1016\/j.lfs.2024.122818_bb0090","doi-asserted-by":"crossref","unstructured":"W. K. Kanagy et al., \u201cDocking of Syk to Fc\u03b5RI is enhanced by Lyn but limited in duration by SHIP1,\u201d Mol. Biol. Cell, vol. 33, no. 10, p. ar89, Sep. 2022, doi:https:\/\/doi.org\/10.1091\/mbc.E21-12-0603.","DOI":"10.1091\/mbc.E21-12-0603"},{"key":"10.1016\/j.lfs.2024.122818_bb0095","doi-asserted-by":"crossref","unstructured":"L. L. Jin et al., \u201cTyrosine phosphorylation of the Lyn Src homology 2 (SH2) domain modulates its binding affinity and specificity,\u201d Mol. Cell. Proteomics, vol. 14, no. 3, pp. 695\u2013706, Mar. 2015, doi:https:\/\/doi.org\/10.1074\/mcp.M114.044404.","DOI":"10.1074\/mcp.M114.044404"},{"key":"10.1016\/j.lfs.2024.122818_bb0100","doi-asserted-by":"crossref","unstructured":"C. A. Lowell, \u201cSrc-family and Syk kinases in activating and inhibitory pathways in innate immune cells: signaling cross talk,\u201d Cold Spring Harb. Perspect. Biol., vol. 3, no. 3, p. a002352, Mar. 2011, doi:https:\/\/doi.org\/10.1101\/cshperspect.a002352.","DOI":"10.1101\/cshperspect.a002352"},{"key":"10.1016\/j.lfs.2024.122818_bb0105","doi-asserted-by":"crossref","unstructured":"T. Zhang, D. F. Finn, J. W. Barlow, and J. J. Walsh, \u201cMast cell stabilisers,\u201d Eur. J. Pharmacol., vol. 778, pp. 158\u2013168, May 2016, doi:https:\/\/doi.org\/10.1016\/j.ejphar.2015.05.071.","DOI":"10.1016\/j.ejphar.2015.05.071"},{"key":"10.1016\/j.lfs.2024.122818_bb0110","doi-asserted-by":"crossref","unstructured":"E. Lefran\u00e7ais et al., \u201cCentral domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells,\u201d Proc. Natl. Acad. Sci. USA, vol. 111, no. 43, pp. 15502\u201315507, Oct. 2014, doi:https:\/\/doi.org\/10.1073\/pnas.1410700111.","DOI":"10.1073\/pnas.1410700111"},{"key":"10.1016\/j.lfs.2024.122818_bb0115","doi-asserted-by":"crossref","unstructured":"J. A. Tolefree et al., \u201cAlcoholic liver disease and mast cells: What's your gut got to do with it?,\u201d Liver Research, vol. 3, no. 1, pp. 46\u201354, Mar. 2019, doi:https:\/\/doi.org\/10.1016\/j.livres.2019.02.002.","DOI":"10.1016\/j.livres.2019.02.002"},{"key":"10.1016\/j.lfs.2024.122818_bb0120","doi-asserted-by":"crossref","unstructured":"C. Cardamone, R. Parente, G. D. Feo, and M. Triggiani, \u201cMast cells as effector cells of innate immunity and regulators of adaptive immunity,\u201d Immunol. Lett., vol. 178, pp. 10\u201314, Oct. 2016, doi:https:\/\/doi.org\/10.1016\/j.imlet.2016.07.003.","DOI":"10.1016\/j.imlet.2016.07.003"},{"key":"10.1016\/j.lfs.2024.122818_bb0125","doi-asserted-by":"crossref","unstructured":"S. Merluzzi, B. Frossi, G. Gri, S. Parusso, C. Tripodo, and C. Pucillo, \u201cMast cells enhance proliferation of B lymphocytes and drive their differentiation toward IgA-secreting plasma cells,\u201d Blood, vol. 115, no. 14, pp. 2810\u20132817, Apr. 2010, doi:https:\/\/doi.org\/10.1182\/blood-2009-10-250126.","DOI":"10.1182\/blood-2009-10-250126"},{"key":"10.1016\/j.lfs.2024.122818_bb0130","doi-asserted-by":"crossref","unstructured":"N. Baumgarth, \u201cThe double life of a B-1 cell: self-reactivity selects for protective effector functions,\u201d Nat. Rev. Immunol., vol. 11, no. 1, pp. 34\u201346, Jan. 2011, doi:https:\/\/doi.org\/10.1038\/nri2901.","DOI":"10.1038\/nri2901"},{"key":"10.1016\/j.lfs.2024.122818_bb0135","doi-asserted-by":"crossref","unstructured":"A. Carroll-Portillo et al., \u201cMast cells and dendritic cells form synapses that facilitate antigen transfer for T cell activation,\u201d J. Cell Biol., vol. 210, no. 5, pp. 851\u2013864, Aug. 2015, doi:https:\/\/doi.org\/10.1083\/jcb.201412074.","DOI":"10.1083\/jcb.201412074"},{"key":"10.1016\/j.lfs.2024.122818_bb0140","doi-asserted-by":"crossref","unstructured":"H. W. Choi et al., \u201cPerivascular dendritic cells elicit anaphylaxis by relaying allergens to mast cells via microvesicles,\u201d Science, vol. 362, no. 6415, p. eaao0666, Nov. 2018, doi:https:\/\/doi.org\/10.1126\/science.aao0666.","DOI":"10.1126\/science.aao0666"},{"key":"10.1016\/j.lfs.2024.122818_bb0145","doi-asserted-by":"crossref","unstructured":"F. R. Ponziani, M. A. Zocco, L. Cerrito, A. Gasbarrini, and M. Pompili, \u201cBacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications,\u201d Expert Rev. Gastroenterol. Hepatol., vol. 12, no. 7, pp. 641\u2013656, Jul. 2018, doi:https:\/\/doi.org\/10.1080\/17474124.2018.1481747.","DOI":"10.1080\/17474124.2018.1481747"},{"key":"10.1016\/j.lfs.2024.122818_bb0150","doi-asserted-by":"crossref","unstructured":"F. Di Vincenzo, A. Del Gaudio, V. Petito, L. R. Lopetuso, and F. Scaldaferri, \u201cGut microbiota, intestinal permeability, and systemic inflammation: a narrative review,\u201d Intern. Emerg. Med., vol. 19, no. 2, pp. 275\u2013293, Mar. 2024, doi:https:\/\/doi.org\/10.1007\/s11739-023-03374-w.","DOI":"10.1007\/s11739-023-03374-w"},{"key":"10.1016\/j.lfs.2024.122818_bb0155","doi-asserted-by":"crossref","unstructured":"K. Rahman et al., \u201cLoss of junctional adhesion molecule a promotes severe steatohepatitis in mice on a diet high in saturated fat, fructose, and cholesterol,\u201d Gastroenterology, vol. 151, no. 4, pp. 733\u2013746.e12, Oct. 2016, doi:https:\/\/doi.org\/10.1053\/j.gastro.2016.06.022.","DOI":"10.1053\/j.gastro.2016.06.022"},{"key":"10.1016\/j.lfs.2024.122818_bb0160","doi-asserted-by":"crossref","unstructured":"W. M. De Vos, H. Tilg, M. Van Hul, and P. D. Cani, \u201cGut microbiome and health: mechanistic insights,\u201d Gut, vol. 71, no. 5, pp. 1020\u20131032, May 2022, doi:https:\/\/doi.org\/10.1136\/gutjnl-2021-326789.","DOI":"10.1136\/gutjnl-2021-326789"},{"key":"10.1016\/j.lfs.2024.122818_bb0165","doi-asserted-by":"crossref","unstructured":"J. H. C. Yiu, B. Dorweiler, and C. W. Woo, \u201cInteraction between gut microbiota and toll-like receptor: from immunity to metabolism,\u201d J. Mol. Med., vol. 95, no. 1, pp. 13\u201320, Jan. 2017, doi:https:\/\/doi.org\/10.1007\/s00109-016-1474-4.","DOI":"10.1007\/s00109-016-1474-4"},{"key":"10.1016\/j.lfs.2024.122818_bb0170","doi-asserted-by":"crossref","unstructured":"K. M. Schneider, S. Albers, and C. Trautwein, \u201cRole of bile acids in the gut-liver axis,\u201d J. Hepatol., vol. 68, no. 5, pp. 1083\u20131085, May 2018, doi:https:\/\/doi.org\/10.1016\/j.jhep.2017.11.025.","DOI":"10.1016\/j.jhep.2017.11.025"},{"key":"10.1016\/j.lfs.2024.122818_bb0175","doi-asserted-by":"crossref","unstructured":"M. Poeta, L. Pierri, and P. Vajro, \u201cGut\u2013liver Axis derangement in non-alcoholic fatty liver disease,\u201d Children, vol. 4, no. 8, p. 66, Aug. 2017, doi:https:\/\/doi.org\/10.3390\/children4080066.","DOI":"10.3390\/children4080066"},{"key":"10.1016\/j.lfs.2024.122818_bb0180","doi-asserted-by":"crossref","unstructured":"J. A. Uranga, V. Mart\u00ednez, and R. Abalo, \u201cMast cell regulation and irritable bowel syndrome: effects of food components with potential nutraceutical use,\u201d Molecules, vol. 25, no. 18, p. 4314, Sep. 2020, doi:https:\/\/doi.org\/10.3390\/molecules25184314.","DOI":"10.3390\/molecules25184314"},{"key":"10.1016\/j.lfs.2024.122818_bb0185","doi-asserted-by":"crossref","unstructured":"D. Zheng, T. Liwinski, and E. Elinav, \u201cInteraction between microbiota and immunity in health and disease,\u201d Cell Res., vol. 30, no. 6, pp. 492\u2013506, Jun. 2020, doi:https:\/\/doi.org\/10.1038\/s41422-020-0332-7.","DOI":"10.1038\/s41422-020-0332-7"},{"key":"10.1016\/j.lfs.2024.122818_bb0190","doi-asserted-by":"crossref","unstructured":"A. Christ, M. Lauterbach, and E. Latz, \u201cWestern diet and the immune system: an inflammatory connection,\u201d Immunity, vol. 51, no. 5, pp. 794\u2013811, Nov. 2019, doi:https:\/\/doi.org\/10.1016\/j.immuni.2019.09.020.","DOI":"10.1016\/j.immuni.2019.09.020"},{"key":"10.1016\/j.lfs.2024.122818_bb0195","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.3389\/fimmu.2018.02414","article-title":"Epigenetic regulation via altered histone acetylation results in suppression of mast cell function and mast cell-mediated food allergic responses","volume":"9","author":"Krajewski","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.122818_bb0200","doi-asserted-by":"crossref","unstructured":"S. R. M. Kinney et al., \u201cCurcumin ingestion inhibits Mastocytosis and suppresses intestinal anaphylaxis in a murine model of food allergy,\u201d PloS One, vol. 10, no. 7, p. e0132467, Jul. 2015, doi:https:\/\/doi.org\/10.1371\/journal.pone.0132467.","DOI":"10.1371\/journal.pone.0132467"},{"key":"10.1016\/j.lfs.2024.122818_bb0205","doi-asserted-by":"crossref","unstructured":"T. D. Shen, N. Pyrsopoulos, and V. K. Rustgi, \u201cMicrobiota and the liver,\u201d Liver Transpl., vol. 24, no. 4, pp. 539\u2013550, Apr. 2018, doi:https:\/\/doi.org\/10.1002\/lt.25008.","DOI":"10.1002\/lt.25008"},{"key":"10.1016\/j.lfs.2024.122818_bb0210","unstructured":"S.-K. Huang, Q. Zhang, Z. Qiu, and K. F. Chung, \u201cMechanistic impact of outdoor air pollution on asthma and allergic diseases,\u201d J. Thorac. Dis., vol. 7, no. 1, pp. 23\u201333, Jan. 2015, doi:https:\/\/doi.org\/10.3978\/j.issn.2072-1439.2014.12.13."},{"key":"10.1016\/j.lfs.2024.122818_bb0215","doi-asserted-by":"crossref","unstructured":"M. Metz et al., \u201cMast cell silencing: a novel therapeutic approach for urticaria and other mast cell-mediated diseases,\u201d Allergy, vol. 79, no. 1, pp. 37\u201351, Jan. 2024, doi:https:\/\/doi.org\/10.1111\/all.15850.","DOI":"10.1111\/all.15850"},{"key":"10.1016\/j.lfs.2024.122818_bb0220","doi-asserted-by":"crossref","unstructured":"D. S. El-Agamy, \u201cTargeting c-kit in the therapy of mast cell disorders: current update,\u201d Eur. J. Pharmacol., vol. 690, no. 1\u20133, pp. 1\u20133, Sep. 2012, doi:https:\/\/doi.org\/10.1016\/j.ejphar.2012.06.030.","DOI":"10.1016\/j.ejphar.2012.06.030"},{"key":"10.1016\/j.lfs.2024.122818_bb0225","doi-asserted-by":"crossref","unstructured":"S. D. Anesi et al., \u201cLirentelimab for severe and chronic forms of allergic conjunctivitis,\u201d J. Allergy Clin. Immunol., vol. 150, no. 3, pp. 631\u2013639, Sep. 2022, doi:https:\/\/doi.org\/10.1016\/j.jaci.2022.03.021.","DOI":"10.1016\/j.jaci.2022.03.021"},{"key":"10.1016\/j.lfs.2024.122818_bb0230","doi-asserted-by":"crossref","unstructured":"X. Niu et al., \u201cGlobal prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis,\u201d BMC Public Health, vol. 23, no. 1, p. 859, May 2023, doi:https:\/\/doi.org\/10.1186\/s12889-023-15749-x.","DOI":"10.1186\/s12889-023-15749-x"},{"key":"10.1016\/j.lfs.2024.122818_bb0235","doi-asserted-by":"crossref","unstructured":"Y. Matsunaga and T. Terada, \u201cMast cell subpopulations in chronic inflammatory hepatobiliary diseases,\u201d Liver, vol. 20, no. 2, pp. 152\u2013156, Apr. 2000, doi:https:\/\/doi.org\/10.1034\/j.1600-0676.2000.020002152.x.","DOI":"10.1034\/j.1600-0676.2000.020002152.x"},{"key":"10.1016\/j.lfs.2024.122818_bb0240","doi-asserted-by":"crossref","unstructured":"C. Beceiro et al., \u201cSerum concentrations of mast cell Tryptase are reduced in heavy drinkers,\u201d Alcohol. Clin. Exp. Res., vol. 39, no. 4, pp. 672\u2013678, Apr. 2015, doi:https:\/\/doi.org\/10.1111\/acer.12682.","DOI":"10.1111\/acer.12682"},{"key":"10.1016\/j.lfs.2024.122818_bb0245","doi-asserted-by":"crossref","unstructured":"V. Mani, S. Arivalagan, A. I. Siddique, and N. Namasivayam, \u201cAntioxidant and anti-inflammatory role of zingerone in ethanol-induced hepatotoxicity,\u201d Mol. Cell. Biochem., vol. 421, no. 1\u20132, pp. 169\u2013181, Oct. 2016, doi:https:\/\/doi.org\/10.1007\/s11010-016-2798-7.","DOI":"10.1007\/s11010-016-2798-7"},{"key":"10.1016\/j.lfs.2024.122818_bb0250","doi-asserted-by":"crossref","unstructured":"M. L. Teng et al., \u201cGlobal incidence and prevalence of nonalcoholic fatty liver disease,\u201d Clin. Mol. Hepatol., vol. 29, no. Suppl, pp. S32\u2013S42, Feb. 2023, doi:https:\/\/doi.org\/10.3350\/cmh.2022.0365.","DOI":"10.3350\/cmh.2022.0365"},{"key":"10.1016\/j.lfs.2024.122818_bb0255","doi-asserted-by":"crossref","unstructured":"M. Benedict and X. Zhang, \u201cNon-alcoholic fatty liver disease: an expanded review,\u201d World J. Hepatol., vol. 9, no. 16, pp. 715\u2013732, Jun. 2017, doi:https:\/\/doi.org\/10.4254\/wjh.v9.i16.715.","DOI":"10.4254\/wjh.v9.i16.715"},{"key":"10.1016\/j.lfs.2024.122818_bb0260","doi-asserted-by":"crossref","unstructured":"B. Franceschini, C. Russo, N. Dioguardi, and F. Grizzi, \u201cIncreased liver mast cell recruitment in patients with chronic C virus-related hepatitis and histologically documented steatosis,\u201d J. Viral Hepat., vol. 14, no. 8, pp. 549\u2013555, Aug. 2007, doi:https:\/\/doi.org\/10.1111\/j.1365-2893.2007.00859.x.","DOI":"10.1111\/j.1365-2893.2007.00859.x"},{"issue":"1","key":"10.1016\/j.lfs.2024.122818_bb0265","first-page":"38","article-title":"\u201cRole of mast cells in the pathogenesis of liver fibrosis in nonalcoholic fatty liver disease,\u201d","volume":"71","author":"Lewandowska","year":"2020"},{"key":"10.1016\/j.lfs.2024.122818_bb0270","doi-asserted-by":"crossref","unstructured":"L. Kennedy et al., \u201cMast cells promote nonalcoholic fatty liver disease phenotypes and microvesicular steatosis in mice fed a Western diet,\u201d Hepatology, vol. 74, no. 1, pp. 164\u2013182, Jul. 2021, doi:https:\/\/doi.org\/10.1002\/hep.31713.","DOI":"10.1002\/hep.31713"},{"key":"10.1016\/j.lfs.2024.122818_bb0275","doi-asserted-by":"crossref","unstructured":"D. Castaneda, A. J. Gonzalez, M. Alomari, K. Tandon, and X. B. Zervos, \u201cFrom hepatitis a to E: a critical review of viral hepatitis,\u201d World J. Gastroenterol., vol. 27, no. 16, pp. 1691\u20131715, Apr. 2021, doi:https:\/\/doi.org\/10.3748\/wjg.v27.i16.1691.","DOI":"10.3748\/wjg.v27.i16.1691"},{"key":"10.1016\/j.lfs.2024.122818_bb0280","doi-asserted-by":"crossref","unstructured":"L. Amiot et al., \u201cExpression of HLA-G by mast cells is associated with hepatitis C virus-induced liver fibrosis,\u201d J. Hepatol., vol. 60, no. 2, pp. 245\u2013252, Feb. 2014, doi:https:\/\/doi.org\/10.1016\/j.jhep.2013.09.006.","DOI":"10.1016\/j.jhep.2013.09.006"},{"issue":"4","key":"10.1016\/j.lfs.2024.122818_bb0285","doi-asserted-by":"crossref","first-page":"736","DOI":"10.4103\/0377-4929.91510","article-title":"Increased liver mast cells in patients with chronic hepatitis C","volume":"54","author":"Koruk","year":"2011","journal-title":"Indian J. Pathol. Microbiol."},{"key":"10.1016\/j.lfs.2024.122818_bb0290","doi-asserted-by":"crossref","unstructured":"M. Belghiti et al., \u201cPotentiation of the transient receptor potential vanilloid 1 channel contributes to pruritogenesis in a rat model of liver disease,\u201d J. Biol. Chem., vol. 288, no. 14, pp. 9675\u20139685, Apr. 2013, doi:https:\/\/doi.org\/10.1074\/jbc.M113.455162.","DOI":"10.1074\/jbc.M113.455162"},{"key":"10.1016\/j.lfs.2024.122818_bb0295","unstructured":"H. Li, L. Zhao, Y. Hao, L. Yin, Y. Zhao, and D. Han, \u201c[Changes in mast cells and hepatic expression of c-kit and stem cell factor in the rat model of chronic hepatitis],\u201d Zhonghua Gan Zang Bing Za Zhi, vol. 21, no. 11, pp. 869\u2013873, Nov. 2013, doi:https:\/\/doi.org\/10.3760\/cma.j.issn.1007-3418.2013.11.016."},{"key":"10.1016\/j.lfs.2024.122818_bb0300","doi-asserted-by":"crossref","unstructured":"R. Weiskirchen, S. K. Meurer, C. Liedtke, and M. Huber, \u201cMast Cells in Liver Fibrogenesis,\u201d Cells, vol. 8, no. 11, p. 1429, Nov. 2019, doi:https:\/\/doi.org\/10.3390\/cells8111429.","DOI":"10.3390\/cells8111429"},{"key":"10.1016\/j.lfs.2024.122818_bb0305","doi-asserted-by":"crossref","unstructured":"M. Zhang et al., \u201cRecruitment or activation of mast cells in the liver aggravates the accumulation of fibrosis in carbon tetrachloride-induced liver injury,\u201d Mol. Immunol., vol. 170, pp. 60\u201375, Jun. 2024, doi:https:\/\/doi.org\/10.1016\/j.molimm.2024.04.009.","DOI":"10.1016\/j.molimm.2024.04.009"},{"key":"10.1016\/j.lfs.2024.122818_bb0310","doi-asserted-by":"crossref","unstructured":"L. Hargrove et al., \u201cBile duct ligation-induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell-deficient KitW-sh mice,\u201d Hepatology, vol. 65, no. 6, pp. 1991\u20132004, Jun. 2017, doi:https:\/\/doi.org\/10.1002\/hep.29079.","DOI":"10.1002\/hep.29079"},{"key":"10.1016\/j.lfs.2024.122818_bb0315","doi-asserted-by":"crossref","unstructured":"A. Villanueva, \u201cHepatocellular Carcinoma,\u201d N. Engl. J. Med., vol. 380, no. 15, pp. 1450\u20131462, Apr. 2019, doi:https:\/\/doi.org\/10.1056\/NEJMra1713263.","DOI":"10.1056\/NEJMra1713263"},{"key":"10.1016\/j.lfs.2024.122818_bb0320","doi-asserted-by":"crossref","unstructured":"L. Pham et al., \u201cMast cells in liver disease progression: an update on current studies and implications,\u201d Hepatology, vol. 75, no. 1, pp. 213\u2013218, Jan. 2022, doi:https:\/\/doi.org\/10.1002\/hep.32121.","DOI":"10.1002\/hep.32121"},{"key":"10.1016\/j.lfs.2024.122818_bb0325","doi-asserted-by":"crossref","unstructured":"G. Hu, S. Wang, and P. Cheng, \u201cTumor-infiltrating tryptase + mast cells predict unfavorable clinical outcome in solid tumors,\u201d Intl Journal of Cancer, vol. 142, no. 4, pp. 813\u2013821, Feb. 2018, doi:https:\/\/doi.org\/10.1002\/ijc.31099.","DOI":"10.1002\/ijc.31099"},{"key":"10.1016\/j.lfs.2024.122818_bb0330","doi-asserted-by":"crossref","unstructured":"R. Liao et al., \u201cHigh expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma,\u201d J. Exp. Clin. Cancer Res., vol. 32, no. 1, p. 3, Jan. 2013, doi:https:\/\/doi.org\/10.1186\/1756-9966-32-3.","DOI":"10.1186\/1756-9966-32-3"},{"key":"10.1016\/j.lfs.2024.122818_bb0335","doi-asserted-by":"crossref","unstructured":"J.-F. Tu, H.-Y. Pan, X.-H. Ying, J. Lou, J.-S. Ji, and H. Zou, \u201cMast cells comprise the major of interleukin 17-producing cells and predict a poor prognosis in hepatocellular carcinoma,\u201d Medicine (Baltimore), vol. 95, no. 13, p. e3220, Mar. 2016, doi:https:\/\/doi.org\/10.1097\/MD.0000000000003220.","DOI":"10.1097\/MD.0000000000003220"},{"key":"10.1016\/j.lfs.2024.122818_bb0340","doi-asserted-by":"crossref","unstructured":"P. L. Nguyen and J. Cho, \u201cPathophysiological roles of histamine receptors in Cancer progression: implications and perspectives as potential molecular targets,\u201d Biomolecules, vol. 11, no. 8, p. 1232, Aug. 2021, doi:https:\/\/doi.org\/10.3390\/biom11081232.","DOI":"10.3390\/biom11081232"},{"key":"10.1016\/j.lfs.2024.122818_bb0345","doi-asserted-by":"crossref","unstructured":"J. Zhao et al., \u201cUpregulation of histamine receptor H1 promotes tumor progression and contributes to poor prognosis in hepatocellular carcinoma,\u201d Oncogene, vol. 39, no. 8, pp. 1724\u20131738, Feb. 2020, doi:https:\/\/doi.org\/10.1038\/s41388-019-1093-y.","DOI":"10.1038\/s41388-019-1093-y"},{"key":"10.1016\/j.lfs.2024.122818_bb0350","doi-asserted-by":"crossref","unstructured":"D. Yu et al., \u201cUpregulated histamine receptor H3 promotes tumor growth and metastasis in hepatocellular carcinoma,\u201d Oncol. Rep., Apr. 2019, doi:https:\/\/doi.org\/10.3892\/or.2019.7119.","DOI":"10.3892\/or.2019.7119"},{"key":"10.1016\/j.lfs.2024.122818_bb0355","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.2147\/OTT.S250655","article-title":"Histamine H3 receptor promotes cell survival via regulating PKA\/CREB\/CDKN1A signal pathway in hepatocellular carcinoma","volume":"13","author":"Zhang","year":"2020","journal-title":"Onco. Targets. Ther."},{"issue":"1","key":"10.1016\/j.lfs.2024.122818_bb0360","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/aja.aja_30_19","article-title":"Effect of ketotifen fumarate on experimental autoimmune orchitis and torsion of the spermatic cord","volume":"22","author":"Moreno","year":"2020","journal-title":"Asian J. Androl."},{"key":"10.1016\/j.lfs.2024.122818_bb0365","doi-asserted-by":"crossref","unstructured":"D. C. Ang, J. Hilligoss, and T. Stump, \u201cMast cell stabilizer (Ketotifen) in fibromyalgia: phase 1 randomized controlled clinical trial,\u201d Clin. J. Pain, vol. 31, no. 9, pp. 836\u2013842, Sep. 2015, doi:https:\/\/doi.org\/10.1097\/AJP.0000000000000169.","DOI":"10.1097\/AJP.0000000000000169"},{"key":"10.1016\/j.lfs.2024.122818_bb0370","doi-asserted-by":"crossref","unstructured":"L. Zhang, Y. Peng, M. Ren, Y. Li, and H. Tang, \u201cIn vitro and in vivo research of sustained release ketotifen fumarate for treatment of asthma,\u201d J. Nanopart. Res., vol. 24, no. 5, p. 94, May 2022, doi:https:\/\/doi.org\/10.1007\/s11051-022-05475-7.","DOI":"10.1007\/s11051-022-05475-7"},{"key":"10.1016\/j.lfs.2024.122818_bb0375","doi-asserted-by":"crossref","unstructured":"W. Y. Abdelzaher, A. H. S. AboBakr Ali, and N. F. G. El-Tahawy, \u201cMast cell stabilizer modulates Sirt1\/Nrf2\/TNF pathway and inhibits oxidative stress, inflammation, and apoptosis in rat model of cyclophosphamide hepatotoxicity,\u201d Immunopharmacol. Immunotoxicol., vol. 42, no. 2, pp. 101\u2013109, Mar. 2020, doi:https:\/\/doi.org\/10.1080\/08923973.2020.1727499.","DOI":"10.1080\/08923973.2020.1727499"},{"key":"10.1016\/j.lfs.2024.122818_bb0380","doi-asserted-by":"crossref","unstructured":"P. G. Puzzovio, T. R. Br\u00fcggemann, H. Pahima, D. Mankuta, B. D. Levy, and F. Levi-Schaffer, \u201cCromolyn sodium differentially regulates human mast cell and mouse leukocyte responses to control allergic inflammation,\u201d Pharmacol. Res., vol. 178, p. 106172, Apr. 2022, doi:https:\/\/doi.org\/10.1016\/j.phrs.2022.106172.","DOI":"10.1016\/j.phrs.2022.106172"},{"key":"10.1016\/j.lfs.2024.122818_bb0385","doi-asserted-by":"crossref","unstructured":"J.-S. Choi et al., \u201cIdentification of cromolyn sodium as an anti-fibrotic agent targeting both hepatocytes and hepatic stellate cells,\u201d Pharmacol. Res., vol. 102, pp. 176\u2013183, Dec. 2015, doi:https:\/\/doi.org\/10.1016\/j.phrs.2015.10.002.","DOI":"10.1016\/j.phrs.2015.10.002"},{"key":"10.1016\/j.lfs.2024.122818_bb0390","doi-asserted-by":"crossref","unstructured":"Pin-Jie Huang, Xiao-Liang Gan, Jian-Pei Liu, De-Zhao Liu, Yan-Ling Wang, and Zi-Qing Hei, \u201cEffects of Anti-Histamine Treatment on Liver Injury Triggered by Small Intestinal Ischemia Reperfusion in Rats,\u201d The Chin. J. Physiol., vol. 57, no. 5, Oct. 2014, doi:https:\/\/doi.org\/10.4077\/CJP.2014.BAC230.","DOI":"10.4077\/CJP.2014.BAC230"},{"key":"10.1016\/j.lfs.2024.122818_bb0395","doi-asserted-by":"crossref","unstructured":"S. Osman et al., \u201cAnti-cancer effects of Tranilast: an update,\u201d Biomed. Pharmacother., vol. 141, p. 111844, Sep. 2021, doi:https:\/\/doi.org\/10.1016\/j.biopha.2021.111844.","DOI":"10.1016\/j.biopha.2021.111844"},{"key":"10.1016\/j.lfs.2024.122818_bb0400","doi-asserted-by":"crossref","unstructured":"S. Darakhshan and A. B. Pour, \u201cTranilast: a review of its therapeutic applications,\u201d Pharmacol. Res., vol. 91, pp. 15\u201328, Jan. 2015, doi:https:\/\/doi.org\/10.1016\/j.phrs.2014.10.009.","DOI":"10.1016\/j.phrs.2014.10.009"},{"key":"10.1016\/j.lfs.2024.122818_bb0405","doi-asserted-by":"crossref","unstructured":"M. Uno et al., \u201cTranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis,\u201d Hepatology, vol. 48, no. 1, pp. 109\u2013118, Jul. 2008, doi:https:\/\/doi.org\/10.1002\/hep.22338.","DOI":"10.1002\/hep.22338"},{"issue":"4","key":"10.1016\/j.lfs.2024.122818_bb0410","first-page":"955","article-title":"Luteolin inhibits mast cell-mediated allergic inflammation","volume":"27","author":"Kritas","year":"2013","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.lfs.2024.122818_bb0415","doi-asserted-by":"crossref","unstructured":"G. Liu et al., \u201cLuteolin alleviates alcoholic liver disease induced by chronic and binge ethanol feeding in mice,\u201d J. Nutr., vol. 144, no. 7, pp. 1009\u20131015, Jul. 2014, doi:https:\/\/doi.org\/10.3945\/jn.114.193128.","DOI":"10.3945\/jn.114.193128"},{"key":"10.1016\/j.lfs.2024.122818_bb0420","doi-asserted-by":"crossref","unstructured":"X. Liu et al., \u201cLuteolin alleviates non-alcoholic fatty liver disease in rats via restoration of intestinal mucosal barrier damage and microbiota imbalance involving in gut-liver axis,\u201d Arch. Biochem. Biophys., vol. 711, p. 109019, Oct. 2021, doi:https:\/\/doi.org\/10.1016\/j.abb.2021.109019.","DOI":"10.1016\/j.abb.2021.109019"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524004089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524004089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T11:03:31Z","timestamp":1725879811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524004089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":84,"alternative-id":["S0024320524004089"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122818","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mast cells and the gut-liver Axis: Implications for liver disease progression and therapy","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122818","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"122818"}}